ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Poster Presentation at the 2013 American Society of Clinical Oncology Annual Meeting
5/16/2013 10:06:12 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Presentation of Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma at ASGCT 16th Annual Meeting
5/16/2013 9:40:47 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces First Quarter Financial Results and Key Developments
5/8/2013 10:22:04 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Presents Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancer
4/9/2013 11:33:19 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Cancer Drug Fails in Late-Stage Trial; Shares Plunge
3/26/2013 7:20:32 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) to Present at the Barclays Global Healthcare Conference
3/7/2013 11:45:32 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Initiation of Indiana University-Sponsored Phase 2 Study of Palifosfamide in Recurrent and Incurable Germ Cell (Testicular and Ovarian) Tumors
3/6/2013 11:17:58 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Treatment for Soft Tissue Sarcoma Meets Study Goals
2/12/2013 7:01:17 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) to Present at the 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 9:06:32 AM
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Announces Third Quarter Financial Results and Key Developments
11/9/2012 10:02:40 AM
More...
|
|